Age
40 - 80
Gender
All
Medical Condition
Parkinson's disease
The TemPo Studies are evaluating the efficacy and safety of
the investigational drug in two different groups of patients:
·
People with early-stage PD (diagnosis within the
past 3 years) who are not currently taking levodopa or dopamine agonists to
manage symptoms
·
People who are currently taking levodopa to
manage PD symptoms
Based on your medical history, the study doctor will
determine whether you may be eligible to participate in one of the TemPo
Studies.
If you are interested in participating in the TemPo Studies,
you will be asked to first read and sign an Informed Consent Form. This form
contains information about the TemPo Studies, including a summary of what you
may expect during study participation, potential risks and benefits, the rights
of study participants, and other options that may be available to you. Once you
have read and signed the Informed Consent Form, your study participation will
begin.
As a study participant there is no guarantee that you will
receive any benefits from being in this study. However, the information
gathered through your participation may help researchers learn new things about
the investigational drug, which could potentially benefit future generations of
people affected by PD.
40 - 80
All
Parkinson's disease